CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma

NCT03473496 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped After CAR-T treatment, the benefit is not significant, and it is difficult to enroll.

Conditions

Interventions

Sponsor

Zhujiang Hospital

Collaborators